| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 115,000 | 05 Jun 2025 | Direct | ||
| Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50,000 | 02 Oct 2024 | Direct | ||
| Axcella Health Inc. | Director | Stock Option (Right to Buy) | 40,000 | 16 Nov 2022 | Direct | ||
| Evelo Biosciences, Inc. | Director | Stock Option (Right to Buy) | 30,000 | 08 Jun 2023 | Direct | ||
| Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 10,000 | 05 Aug 2025 | Direct |